Cargando…
Clinical Effectiveness of Sacubitril/Valsartan Among Patients Hospitalized for Heart Failure With Reduced Ejection Fraction
BACKGROUND: Sacubitril/Valsartan has been highly efficacious in randomized trials of heart failure with reduced ejection fraction (HFrEF). However, the effectiveness of sacubitril/valsartan in older patients hospitalized for HFrEF in real‐world US practice is unclear. METHODS AND RESULTS: This study...
Autores principales: | Greene, Stephen J., Choi, Sujung, Lippmann, Steven J., Mentz, Robert J., Greiner, Melissa A., Hardy, N. Chantelle, Hammill, Bradley G., Luo, Nancy, Samsky, Marc D., Heidenreich, Paul A., Laskey, Warren K., Yancy, Clyde W., Peterson, Pamela N., Curtis, Lesley H., Hernandez, Adrian F., Fonarow, Gregg C., O'Brien, Emily C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475054/ https://www.ncbi.nlm.nih.gov/pubmed/34350772 http://dx.doi.org/10.1161/JAHA.121.021459 |
Ejemplares similares
-
Relationship Between Hospital Characteristics and Early Adoption of Angiotensin‐Receptor/Neprilysin Inhibitor Among Eligible Patients Hospitalized for Heart Failure
por: Luo, Nancy, et al.
Publicado: (2019) -
Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
por: Dewan, Pooja, et al.
Publicado: (2019) -
Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021) -
Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction
por: McMurray, John J V, et al.
Publicado: (2018) -
Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
por: Selvaraj, Senthil, et al.
Publicado: (2021)